---
id: 031
title: Carbapenem Spectrum Comparison (IMErD)
category: antimicrobials
subcategory: carbapenems
tags: [carbapenem, imipenem, meropenem, ertapenem, doripenem, IMErD]
difficulty: medium
---

## Question

Compare the four carbapenems using the **IMErD** mnemonic. Which one does NOT cover *Pseudomonas*?

## Answer

**IMErD mnemonic for carbapenems:**

| Feature | **I**mipenem | **M**eropenem | **Er**tapenem | **D**oripenem |
|---------|--------------|---------------|---------------|---------------|
| ***Pseudomonas*** | Yes | Yes | **NO** | Yes |
| **Enterococcus** | *E. faecalis* only | *E. faecalis* only | **NO** | *E. faecalis* only |
| ***Acinetobacter*** | Yes | Yes | **NO** | Yes |
| **Anaerobes** | Yes | Yes | Yes | Yes |
| **ESBL coverage** | Yes | Yes | Yes | Yes |
| **Dosing interval** | q6-8h | q8h | **q24h** | q8h |
| **Half-life** | ~1 hour | ~1 hour | **~4 hours** | ~1 hour |
| **CNS penetration** | Poor (seizures) | Good | Moderate | Good |

### **"APE" Mnemonic for Ertapenem Gaps:**
Ertapenem does NOT cover:
- **A**cinetobacter
- **P**seudomonas
- **E**nterococcus

### **Broad-Spectrum (IMD):**
- Imipenem, Meropenem, Doripenem = anti-*Pseudomonas* carbapenems
- Cover: Enterobacterales (including ESBL), *Pseudomonas*, *Acinetobacter*, anaerobes, Gram-positives (MSSA, Strep)

### **Narrow-Spectrum (Er):**
- Ertapenem = community carbapenem
- Cover: Enterobacterales (including ESBL), anaerobes, Gram-positives
- **Ideal for:** ESBL UTI, intra-abdominal infections, outpatient IV therapy (OPAT)

## Key Points

### **When to Use Ertapenem:**
- ESBL-producing Enterobacterales (non-severe)
- Outpatient parenteral therapy (once-daily dosing)
- NO *Pseudomonas* risk
- **Carbapenem-sparing strategy** (does NOT induce *Pseudomonas* resistance)

### **When to Use Meropenem/Imipenem/Doripenem:**
- *Pseudomonas* coverage needed
- Severe sepsis/critically ill
- Nosocomial infections
- Meningitis (meropenem preferred - lower seizure risk)

### **Meropenem vs Imipenem:**
- **Meropenem:** Lower seizure risk, better CNS penetration, preferred for meningitis
- **Imipenem:** Must be combined with cilastatin (prevents renal metabolism), higher seizure risk

## Sources

- [PubMed: Comparative Review of Carbapenems]
- [IDSA 2024: AMR Gram-Negative Infections Guidance]
- [Healio: Are All Carbapenems the Same?]

## Media

N/A
